Changsha Duole Technology
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Changsha Duole Technology between 5 Oct 2025 and 27 Apr 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Changsha Duole Technology
Retatrutide
Tested 5 Samples
Last test 27 Apr 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Changsha Duole Technology
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
27 Apr 2026
First
5 Oct 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 27 Apr 2026 | View | 5mg | ⚠️ Sample does not contain Retatrutide | n/a | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |||
| 3 Mar 2026 | View | 10mg | 8.81mg | -11.9% | 99.90% | n/a | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 23 Dec 2025 | View | 5mg | 4.07mg | -18.6% | 99.95% | not detected | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 9 Oct 2025 | View | 20mg | 18.5mg | -7.5% | 99.59% | n/a | (no batch ID) | (no data) | Lab E | Public | |
| 5 Oct 2025 | View | 20mg | 19.2mg | -4.0% | 99.75% | n/a | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |